Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VBIV

VBI Vaccines (VBIV) Stock Price, News & Analysis

VBI Vaccines logo

About VBI Vaccines Stock (NASDAQ:VBIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.02
$0.79
52-Week Range
N/A
Volume
29.90 million shs
Average Volume
3.66 million shs
Market Capitalization
$1.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VBIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

VBIV Stock News Headlines

How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback.
Why Is VBI Vaccines (VBIV) Stock Up 62% Today?
See More Headlines

VBIV Stock Analysis - Frequently Asked Questions

VBI Vaccines Inc. (NASDAQ:VBIV) issued its earnings results on Monday, March, 13th. The biopharmaceutical company reported ($1.60) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.40) by $0.20. The biopharmaceutical company earned $0.29 million during the quarter, compared to analysts' expectations of $1.98 million. VBI Vaccines had a negative net margin of 881.79% and a negative trailing twelve-month return on equity of 525.42%.

VBI Vaccines shares reverse split on Wednesday, April 12th 2023.The 1-20 reverse split was announced on Wednesday, April 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that VBI Vaccines investors own include Inovio Pharmaceuticals (INO), VAXART (VXRT), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Pfizer (PFE) and Novavax (NVAX).

Company Calendar

Last Earnings
3/13/2023
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VBIV
Fax
N/A
Employees
22
Year Founded
2001

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$92.84 million
Net Margins
-881.79%
Pretax Margin
-881.79%

Debt

Sales & Book Value

Annual Sales
$9.41 million
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
N/A

Miscellaneous

Free Float
25,713,000
Market Cap
$1.87 million
Optionable
Optionable
Beta
2.18

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:VBIV) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners